Resonant Capital Advisors’s iShares iBonds Dec 2026 Term Corporate ETF IBDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.99M Sell
247,125
-9,982
-4% -$242K 0.29% 62
2026
Q1
$6.23M Sell
257,107
-1,079
-0.4% -$26.1K 0.33% 56
2025
Q4
$6.26M Buy
258,186
+11,010
+4% +$267K 0.34% 52
2025
Q3
$6.01M Buy
247,176
+60,362
+32% +$1.46M 0.35% 54
2025
Q2
$4.53M Buy
186,814
+7,440
+4% +$180K 0.29% 69
2025
Q1
$4.34M Buy
179,374
+2,077
+1% +$50.1K 0.3% 67
2024
Q4
$4.27M Buy
177,297
+55,493
+46% +$1.34M 0.31% 65
2024
Q3
$2.96M Buy
121,804
+94,240
+342% +$2.27M 0.22% 86
2024
Q2
$657K Buy
27,564
+8,417
+44% +$200K 0.05% 179
2024
Q1
$457K Buy
+19,147
New +$456K 0.04% 207

Other funds holding IBDR

Resonant Capital Advisors's IBDR Position: Q2 2026 in Review

Resonant Capital Advisors reduced its iShares iBonds Dec 2026 Term Corporate ETF (IBDR) stake by 3.9% in Q2 2026, selling an estimated $242K and leaving 247,125 shares worth $5.99M. The position accounts for 0.29% of the portfolio, ranked #62.

Resonant Capital Advisors first reported a position in IBDR in Q1 2024 and has held it in 10 quarters since. The position peaked at $6.26M in Q4 2025. 222 funds tracked by Wall St. Rank hold IBDR as of Q2 2026.

  • Resonant Capital Advisors held 247,125 shares of iShares iBonds Dec 2026 Term Corporate ETF worth $5.99M as of Q2 2026.
  • Resonant Capital Advisors sold 9,982 iShares iBonds Dec 2026 Term Corporate ETF shares in Q2 2026, an estimated $242K.
  • iShares iBonds Dec 2026 Term Corporate ETF made up 0.29% of Resonant Capital Advisors's portfolio in Q2 2026, its #62 holding.
  • Resonant Capital Advisors first reported a position in iShares iBonds Dec 2026 Term Corporate ETF in Q1 2024 and has held it in 10 quarters since.
  • Resonant Capital Advisors's iShares iBonds Dec 2026 Term Corporate ETF position peaked at $6.26M in Q4 2025.
  • 222 funds tracked by Wall St. Rank held iShares iBonds Dec 2026 Term Corporate ETF as of Q2 2026.

Based on Resonant Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.